Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1973 2
1974 1
1975 1
1976 1
1977 1
1978 1
1979 1
1980 1
1982 2
1983 2
1984 1
1985 2
1986 1
1989 1
1990 4
1991 3
1992 2
1993 3
1994 3
1995 4
1996 4
1997 2
1998 7
1999 8
2000 8
2001 4
2002 5
2003 17
2004 14
2005 18
2006 22
2007 27
2008 26
2009 22
2010 23
2011 35
2012 31
2013 57
2014 40
2015 42
2016 30
2017 46
2018 58
2019 62
2020 74
2021 80
2022 81
2023 85
2024 76
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

911 results

Results by year

Filters applied: . Clear all
Page 1
Congenital Diarrheal Diseases.
Younis M, Rastogi R, Chugh A, Rastogi S, Aly H. Younis M, et al. Among authors: rastogi s. Clin Perinatol. 2020 Jun;47(2):301-321. doi: 10.1016/j.clp.2020.02.007. Epub 2020 Mar 5. Clin Perinatol. 2020. PMID: 32439113 Review.
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
Giudice E, Huang TT, Nair JR, Zurcher G, McCoy A, Nousome D, Radke MR, Swisher EM, Lipkowitz S, Ibanez K, Donohue D, Malys T, Lee MJ, Redd B, Levy E, Rastogi S, Sato N, Trepel JB, Lee JM. Giudice E, et al. Among authors: rastogi s. Nat Commun. 2024 Mar 30;15(1):2805. doi: 10.1038/s41467-024-47215-6. Nat Commun. 2024. PMID: 38555285 Free PMC article. Clinical Trial.
Buparlisib in breast cancer.
Sirohi B, Rastogi S, Dawood S. Sirohi B, et al. Among authors: rastogi s. Future Oncol. 2015;11(10):1463-70. doi: 10.2217/fon.15.56. Future Oncol. 2015. PMID: 25963424 Review.
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Apolo AB, Girardi DM, Niglio SA, Nadal R, Kydd AR, Simon N, Ley L, Cordes LM, Chandran E, Steinberg SM, Lee S, Lee MJ, Rastogi S, Sato N, Cao L, Banday AR, Boudjadi S, Merino MJ, Toubaji A, Akbulut D, Redd B, Bagheri H, Costello R, Gurram S, Agarwal PK, Chalfin HJ, Valera V, Streicher H, Wright JJ, Sharon E, Figg WD, Parnes HL, Gulley JL, Saraiya B, Pal SK, Quinn D, Stein MN, Lara PN, Bottaro DP, Mortazavi A. Apolo AB, et al. Among authors: rastogi s. J Clin Oncol. 2024 Sep 1;42(25):3033-3046. doi: 10.1200/JCO.23.02233. Epub 2024 Jul 2. J Clin Oncol. 2024. PMID: 38954785 Free PMC article. Clinical Trial.
911 results